These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease. Schuppan D; Besser M; Schwarting R; Hahn EG J Clin Invest; 1986 Jul; 78(1):241-8. PubMed ID: 3722378 [TBL] [Abstract][Full Text] [Related]
45. [Serum type III procollagen peptide in tissue fibrosis]. Maruyama K Rinsho Byori; 1985 Jan; 33(1):27-32. PubMed ID: 3990010 [No Abstract] [Full Text] [Related]
46. Ito cells and fibrogenesis in chronic alcoholic liver disease. González-Reimers CE; Brajín-Rodríguez MM; Santolaria-Fernández F; Diaz-Flores L; Conde-Martel A; Rodríguez-Rodríguez E; Essardas-Daryanani H Drug Alcohol Depend; 1992 Feb; 29(3):225-30. PubMed ID: 1559427 [TBL] [Abstract][Full Text] [Related]
47. Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis? Mutimer DJ; Bassendine MF; Kelly P; James OF J Hepatol; 1989 Sep; 9(2):184-9. PubMed ID: 2809158 [TBL] [Abstract][Full Text] [Related]
48. [Clinical usefulness of serum procollagen-III-peptide in patients with solid tumor]. Takahashi T; Takami H; Abe O; Ootake T; Kano S Gan To Kagaku Ryoho; 1984 Jul; 11(7):1480-6. PubMed ID: 6204598 [TBL] [Abstract][Full Text] [Related]
49. Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Schytte S; Hansen M; Møller S; Junker P; Henriksen JH; Hillingsø J; Teisner B Scand J Clin Lab Invest; 1999 Dec; 59(8):627-33. PubMed ID: 10691054 [TBL] [Abstract][Full Text] [Related]
51. [Assay of an amino propeptide of procollagen III in hepatic pathology]. Lefrère JJ; Arrago JP; Poirier O; Najean Y Ann Med Interne (Paris); 1987; 138(8):667. PubMed ID: 3450217 [No Abstract] [Full Text] [Related]
52. [Correlation between adhesive factors of primary hemostasis and liver fibrogenesis in alcoholic live cirrhosis]. Udvardy M; Hársfalvi J; Pósán E; Káplár M; Katona E; Rák K Orv Hetil; 1994 Mar; 135(10):523-6. PubMed ID: 8146008 [TBL] [Abstract][Full Text] [Related]
53. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions. Gressner AM; Tittor W; Negwer A Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173 [TBL] [Abstract][Full Text] [Related]
54. [Amino-terminal procollagen type-III peptide and hepatic fibrogenesis]. Castilla Cortázar A Med Clin (Barc); 1993 Mar; 100(11):436. PubMed ID: 8464262 [No Abstract] [Full Text] [Related]
56. [Markers of hepatic fibrogenesis in alcoholic patients]. de la Maza MP; Chichester C; Hirsch S; Petermann M; Iturriaga H; Bunout D Rev Med Chil; 1997 Jan; 125(1):15-21. PubMed ID: 9336064 [TBL] [Abstract][Full Text] [Related]
58. The relationship between procollagen-III-peptide and the severity of esophageal varices in children with biliary atresia after Kasai operation. Sathienkijakarnchai P; Chongsrisawat V; Charoensapaya J; Tanprayoon T; Chandrakamol B; Suwangool P; Poovorawan Y Pediatr Surg Int; 2002 Jan; 18(1):32-5. PubMed ID: 11793060 [TBL] [Abstract][Full Text] [Related]
59. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer]. Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978 [TBL] [Abstract][Full Text] [Related]
60. [Trace elements (copper, zinc, magnesium) in portal and biliary liver cirrhosis]. Sajewicz Z; Knapik Z; Bulak Z; Rudolf M Wiad Lek; 1987 Dec; 40(24):1677-9. PubMed ID: 3451603 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]